CRNC Form 144 Notice — 4,000 Restricted Shares to Be Sold via Morgan Stanley

Rhea-AI Filing Summary

Cerence Inc. (CRNC) filed a Form 144 notice reporting a proposed sale of 4,000 shares of common stock, with an aggregate market value of $50,943.20. The shares are part of an issuance recorded as restricted stock acquired from the issuer on 10/01/2024 and were paid in full on that date. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an approximate sale date of 08/14/2025 on the NASDAQ. Total shares outstanding are reported as 43,319,651. The filer affirms they do not possess undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Small insider sale notice — 4,000 shares (~$50.9k) proposed for sale; immaterial relative to outstanding stock.

The Form 144 documents a proposed disposition of 4,000 restricted shares acquired from the issuer on 10/01/2024. With 43,319,651 shares outstanding, this block represents roughly 0.009% of the outstanding stock, indicating limited market impact. The use of a major broker and a future approximate sale date are routine. The filing includes the standard representation that no undisclosed material adverse information is known to the seller.

Compliance Officer

TL;DR: Filing appears procedurally complete for Rule 144 notice; broker and acquisition details are provided.

The notice includes required details: class, number of shares, aggregate market value, acquisition date and nature (restricted stock), broker identity, and an approximate sale date. The signer provides the customary certification about material information. No reportable sales in the prior three months are listed. From a compliance perspective, the document contains the essential disclosures for a Rule 144 notification.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4000	50943.20	43319651	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2024	Restricted Stock	Issuer			4000	10/01/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Cerence (CRNC) report?

The Form 144 reports a proposed sale of 4,000 common shares with an aggregate market value of $50,943.20.

When were the shares acquired and what was the nature of acquisition?

The 4,000 shares were acquired on 10/01/2024 as restricted stock from the issuer, with payment noted on 10/01/2024.

Which broker is named in the CRNC Form 144 filing?

Morgan Stanley Smith Barney LLC is listed as the broker, with an address at 1 New York Plaza, 8th Floor, New York, NY 10004.

What is the approximate date of the proposed sale?

The filing lists an approximate sale date of 08/14/2025 on the NASDAQ.

How large is the proposed sale relative to outstanding shares?

The filing reports 43,319,651 shares outstanding; 4,000 shares represent approximately 0.009% of that total.